BCM
Boone Capital Management Portfolio holdings
AUM
$233M
This Quarter Return
-9.04%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$214M
AUM Growth
+$214M
(+9.6%)
Cap. Flow
+$28.1M
Cap. Flow
% of AUM
13.17%
Top 10 Holdings %
Top 10 Hldgs %
93.61%
Holding
20
New
3
Increased
9
Reduced
–
Closed
8
Top Buys
| 1 |
Amgen
AMGN
|
$19.1M |
| 2 |
Baxter International
BAX
|
$14.4M |
| 3 |
Molina Healthcare
MOH
|
$14.2M |
| 4 |
Cigna
CI
|
$11.1M |
| 5 |
Danaher
DHR
|
$8.62M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$17.4M |
| 2 |
Organon & Co
OGN
|
$13.9M |
| 3 |
Abbott
ABT
|
$12.3M |
| 4 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$10.6M |
| 5 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$7.16M |
Sector Composition
| 1 | Healthcare | 84.12% |
| 2 | Financials | 15.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Unum
UNM
$11.9B
| $33.9M | 15.88% |
857,565
+186,035
| +28% | +$7.36M |
|
|
2
Cigna
CI
$80.3B
| $26.2M | 12.27% |
102,623
+43,594
| +74% | +$11.1M |
|
|
3
Molina Healthcare
MOH
$9.93B
| $24.7M | 11.57% |
92,412
+52,968
| +134% | +$14.2M |
|
|
4
Danaher
DHR
$146B
| $22.3M | 10.45% |
88,538
+34,182
| +63% | +$8.62M |
|
|
5
Amgen
AMGN
$154B
| $19.1M | 8.96% |
+79,150
| New | +$19.1M |
|
6
Enovis
ENOV
$1.76B
| $18.2M | 8.51% |
339,758
+63,512
| +23% | +$3.4M |
|
7
Biogen
BIIB
$20.5B
| $16.5M | 7.75% |
59,522
+17,679
| +42% | +$4.92M |
|
|
8
Baxter International
BAX
$12.4B
| $14.4M | 6.73% |
+354,443
| New | +$14.4M |
|
9
AbbVie
ABBV
$374B
| $14M | 6.57% |
88,026
+12,153
| +16% | +$1.94M |
|
10
TruBridge
TBRG
$300M
| $10.5M | 4.94% |
349,245
+121,880
| +54% | +$3.68M |
|
|
CERE
11
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $7.32M | 3.43% |
+300,000
| New | +$7.32M |
|
12
Quanterix
QTRX
$209M
| $6.32M | 2.96% |
561,144
+70,919
| +14% | +$799K |
|
|
13
Abbott
ABT
$229B
| – | – |
-112,106
| Closed | -$12.3M |
|
|
AFMD
14
DELISTED
Affimed
AFMD
| – | – |
-2,869,744
| Closed | -$3.56M |
|
15
Cabaletta Bio
CABA
$133M
| – | – |
-266,882
| Closed | -$2.47M |
|
|
16
Eli Lilly
LLY
$659B
| – | – |
-47,448
| Closed | -$17.4M |
|
|
17
Organon & Co
OGN
$2.45B
| – | – |
-498,262
| Closed | -$13.9M |
|
|
MDRX
18
DELISTED
Veradigm Inc. Common Stock
MDRX
| – | – |
-600,000
| Closed | -$10.6M |
|
|
CSII
19
DELISTED
Cardiovascular Systems, Inc.
CSII
| – | – |
-99,157
| Closed | -$1.35M |
|
|
APEN
20
DELISTED
Apollo Endosurgery, Inc.
APEN
| – | – |
-718,419
| Closed | -$7.16M |
|